Skip to main content
Livermore
Livermore
ZHEN

Assetmark, Inc

SEC CIK
0001344551
Latest filing
Jul 30, 2026

BIO holding history

Bio-Rad Laboratories, Inc. in every 13F filed by Assetmark, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BIO overviewAll 13F holders of BIOFull Q2 2026 holdings

Shares (Q2 2026)
44,277
Value
$13.0M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BIO by Assetmark, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202644,277$13.0M<0.1%+5,288+13.6%AddedHolders
Q1 202638,989$10.9M<0.1%+6,224+19.0%AddedHolders
Q4 202532,765$9.93M<0.1%+3,957+13.7%AddedHolders
Q3 202528,808$8.08M<0.1%+7,633+36.0%AddedHolders
Q2 202521,175$5.11M<0.1%+12,023+131.4%AddedHolders
Q1 20259,152$2.23M<0.1%+1,242+15.7%AddedHolders
Q4 20247,910$2.60M<0.1%+7,605+2,493.4%AddedHolders
Q3 2024305$102.0K<0.1%+140+84.8%AddedHolders
Q2 2024165$45.1K<0.1%−16,794−99.0%ReducedHolders
Q1 202416,959$5.87M<0.1%+16+0.1%AddedHolders
Q4 202316,943$5.47M<0.1%−1,861−9.9%ReducedHolders
Q3 202318,804$6.74M<0.1%+1,246+7.1%AddedHolders
Q2 202317,558$6.66M<0.1%−937−5.1%ReducedHolders
Q1 202318,495$8.86M<0.1%+1,380+8.1%AddedHolders
Q4 202217,115$7.20M<0.1%−2,192−11.4%ReducedHolders
Q3 202219,307$8.05M<0.1%−113,290−85.4%ReducedHolders
Q2 2022132,597$65.6M0.3%−11,599−8.0%ReducedHolders
Q1 2022144,196$81.2M0.3%−1,576−1.1%ReducedHolders
Q4 2021145,772$110.1M0.5%+6,935+5.0%AddedHolders
Q3 2021138,837$103.6M0.5%−7,253−5.0%ReducedHolders
Q2 2021146,090$94.1M0.4%+6,713+4.8%AddedHolders
Q1 2021139,377$79.6M0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.